ENDED on 31/03/17 but open ONLY FOR ARCHIVING AND PUBLISHING COST .(EPIVIN) - Phase II clinical trial investigating the use of epigallocatechin-3-gallate (Veregen) in the treatment of vulval intraepithelial neoplasia

Project Details

Short titleENDED on 31/03/17 but open ONLY FOR ARCHIVING AND PUBLISHING COST .(EPIVIN) - Phase II clinical trial investigating the use of epigallocatechin-3-gallate (Veregen) in the treatment of vulval intraepithelial neoplasia
StatusFinished
Effective start/end date1/04/14 → 31/12/20

Funding

  • NIHR